Published in J Anat on May 01, 1999
Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci (2011) 1.71
Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat. Br J Pharmacol (2004) 1.25
Pathophysiology of migraine. Ann Indian Acad Neurol (2012) 1.14
Migraine: where and how does the pain originate? Exp Brain Res (2009) 1.06
CGRP and migraine: could PACAP play a role too? Neuropeptides (2013) 0.90
Review of frovatriptan in the treatment of migraine. Neuropsychiatr Dis Treat (2008) 0.90
Ion channels and migraine. Headache (2014) 0.82
Pathophysiology of Migraine: A Disorder of Sensory Processing. Physiol Rev (2017) 0.81
Neurovascular contributions to migraine: Moving beyond vasodilation. Neuroscience (2016) 0.80
5-HT7 receptor-mediated dilatation in the middle meningeal artery of anesthetized rats. Eur J Pharmacol (2007) 0.79
Triptans attenuate capsaicin-induced CREB phosphorylation within the trigeminal nucleus caudalis: a mechanism to prevent central sensitization? J Headache Pain (2011) 0.79
Donitriptan, but not sumatriptan, inhibits capsaicin-induced canine external carotid vasodilatation via 5-HT1B rather than 5-HT1D receptors. Br J Pharmacol (2006) 0.78
Increase of capsaicin-induced trigeminal Fos-like immunoreactivity by 5-HT(7) receptors. Headache (2011) 0.78
Innervation of the cerebral dura mater. Neuroradiol J (2014) 0.75
Morphometric analysis of the middle meningeal artery organization in humans-embryological considerations. J Neurol Surg B Skull Base (2013) 0.75
Investigation of the immunoreactivities of NOS enzymes and the effect of sumatriptan in adolescent rats using an experimental model of migraine. J Headache Pain (2008) 0.75
Abnormality of the Foramen Spinosum due to a Variation in the Trajectory of the Middle Meningeal Artery: A Case Report in Human. J Neurol Surg Rep (2013) 0.75
Metabotropic glutamate receptor 5: a target for migraine therapy. Ann Clin Transl Neurol (2016) 0.75
An update on migraine: current understanding and future directions. J Neurol (2017) 0.75
A cytoarchitectonic atlas of the spinal cord in the cat. J Comp Neurol (1954) 3.42
Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol (1990) 3.25
The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol (1993) 3.07
Vasoactive peptide levels in the plasma of young migraine patients with and without aura assessed both interictally and ictally. Cephalalgia (1995) 1.90
Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system. Ann Neurol (1988) 1.77
FUNCTIONAL ORGANIZATION IN THE TRIGEMINAL MAIN SENSORY AND ROSTRAL SPINAL NUCLEI OF THE CAT. J Physiol (1963) 1.67
Afferent connections to the sensory trigeminal nuclei, the nucleus of the solitary tract and adjacent structures; an experimental study in the rat. J Comp Neurol (1956) 1.60
Possible mechanism of c-fos expression in trigeminal nucleus caudalis following cortical spreading depression. Pain (1997) 1.54
Neocortical spreading depression provokes the expression of c-fos protein-like immunoreactivity within trigeminal nucleus caudalis via trigeminovascular mechanisms. J Neurosci (1993) 1.50
The macro and microvasculature of the dura mater. Neuroradiology (1973) 1.50
Perivascular meningeal projections from cat trigeminal ganglia: possible pathway for vascular headaches in man. Science (1981) 1.48
Trigeminal projections to supratentorial pial and dural blood vessels in cats demonstrated by horseradish peroxidase histochemistry. J Comp Neurol (1984) 1.47
Expression of c-fos protein in interneurons and projection neurons of the rat spinal cord in response to noxious somatic, articular, and visceral stimulation. J Comp Neurol (1989) 1.38
Four aspects of trigeminal nucleus and a paradox. J Neurophysiol (1962) 1.33
Substance P: immunohistochemical localization and effect upon cat pial arteries in vitro and in situ. J Physiol (1981) 1.22
Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res (1993) 1.21
Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). I. Responses to oral-facial noxious and nonnoxious stimuli and projections to thalamus and subnucleus oralis. J Neurophysiol (1981) 1.20
Peptidergic and serotoninergic innervation of the rat dura mater. J Comp Neurol (1991) 1.17
Pattern of intracranial and extracranial projections of trigeminal ganglion cells. J Neurosci (1986) 1.16
Central distribution of trigeminal and upper cervical primary afferents in the rat studied by anterograde transport of horseradish peroxidase conjugated to wheat germ agglutinin. J Comp Neurol (1988) 1.15
A SINGLE-NEURONE INVESTIGATION OF SOMATOTOPIC ORGANIZATION WITHIN THE CAT'S TRIGEMINAL BRAIN-STEM NUCLEI. J Physiol (1963) 1.14
Focal headache during balloon inflation in the internal carotid and middle cerebral arteries. Stroke (1990) 1.13
The tentorial nerves and Iocalization of intracranial pain in man. Neurology (1960) 1.10
The distribution of trigeminovascular afferents in the nonhuman primate brain Macaca nemestrina: a c-fos immunocytochemical study. J Anat (1997) 1.08
Distribution of fos-like immunoreactivity in the medullary and upper cervical dorsal horn produced by stimulation of dural blood vessels in the rat. J Neurosci (1994) 1.08
Origin and distribution of cerebral vascular innervation from superior cervical, trigeminal and spinal ganglia investigated with retrograde and anterograde WGA-HRP tracing in the rat. Neuroscience (1986) 1.07
Response of brainstem trigeminal neurons to electrical stimulation of the dura. Brain Res (1986) 1.07
Innervation of the feline cerebral vasculature by nerve fibers containing calcitonin gene-related peptide: trigeminal origin and co-existence with substance P. Neurosci Lett (1985) 1.07
Trigeminal nerve pathways to the cerebral arteries in monkeys. J Anat (1987) 1.06
Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain (1996) 1.05
Expression of c-fos-like immunoreactivity in brainstem after meningeal irritation by blood in the subarachnoid space. Neuroscience (1992) 1.04
The effect of stimulus duration on noxious-stimulus induced c-fos expression in the rodent spinal cord. Brain Res (1992) 1.01
SUMATRIPTAN: a receptor-targeted treatment for migraine. Annu Rev Med (1993) 0.98
Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain (1996) 0.98
Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci (1988) 0.98
The central projections of trigeminal primary afferent neurons in the cat as determined by the tranganglionic transport of horseradish peroxidase. J Comp Neurol (1981) 0.97
Headaches during intracranial endovascular procedures: a possible model of vascular headache. Headache (1993) 0.96
Microvascularization of the intracranial dura mater. Surg Radiol Anat (1987) 0.95
Somatotopic organization in the spinal trigeminal nucleus, the dorsal column nuclei and related structures in the rat. J Comp Neurol (1967) 0.92
Terminal distribution of primary afferent trigeminal fibers in the rat. Exp Neurol (1962) 0.92
Focal headache during balloon inflation in the vertebral and basilar arteries. Headache (1993) 0.91
Overall distribution of substance P-containing nerves in the wall of the cerebral arteries of the guinea pig and its origins. J Comp Neurol (1983) 0.91
Sympathetic innervation of the supratentorial dura mater of the rat. J Comp Neurol (1989) 0.89
Brain stem terminations of the trigeminal and upper spinal ganglia innervation of the cerebrovascular system: WGA-HRP transganglionic study. J Cereb Blood Flow Metab (1988) 0.89
Cerebral arterial innervations in man. Arch Neurol (1961) 0.88
Activation of trigeminal brain-stem nociceptive neurons by dural artery stimulation. Pain (1986) 0.88
Morphine or U-50,488 suppresses Fos protein-like immunoreactivity in the spinal cord and nucleus tractus solitarii evoked by a noxious visceral stimulus in the rat. J Comp Neurol (1992) 0.88
A simple method, using 2-hydroxypropyl-beta-cyclodextrin, of administering alpha-chloralose at room temperature. J Neurosci Methods (1997) 0.87
Primate spinothalamic pathways: I. A quantitative study of the cells of origin of the spinothalamic pathway. J Comp Neurol (1989) 0.87
5HT1B and 5HT1D receptor mRNA differential co-localization with peptide mRNA in the guinea pig trigeminal ganglion. Neuroreport (1998) 0.87
The trigeminal system in the pigeon (Columba livia). I. Projections of the gasserian ganglion. J Comp Neurol (1978) 0.85
Trigeminal primary afferents project bilaterally to dorsal horn and ipsilaterally to cerebellum, reticular formation, and cuneate, solitary, supratrigeminal and vagal nuclei. Brain Res (1982) 0.85
Descending projections from the marginal cell layer and other regions of the monkey spinal cord. Brain Res (1976) 0.85
Somatotopy of spinal nociceptive processing. J Comp Neurol (1991) 0.84
Innervation of the posterior fossa dura of the cat. Brain Res Bull (1985) 0.84
Transganglionic degeneration in trigeminal primary sensory neurons. Brain Res (1975) 0.83
The Bötzinger complex as the pattern generator for retching and vomiting in the dog. Neurosci Res (1991) 0.83
Somatotopic organization of mechanoreceptor units in the trigeminal nuclear complex of the macaque. J Comp Neurol (1968) 0.83
Origins and distribution of calcitonin gene-related peptide-containing nerves in the wall of the cerebral arteries of the guinea pig with special reference to the coexistence with substance P. Brain Res (1986) 0.82
The distribution of nine peptides in rat spinal cord with special emphasis on the substantia gelatinosa and on the area around the central canal (lamina X). J Comp Neurol (1981) 0.81
The sensory representation of the dura mater in the trigeminal ganglion of the cat. Neurosci Lett (1982) 0.81
Transganglionic degeneration in the spinal trigeminal nucleus following removal of tooth pulps in adult cats. Brain Res (1976) 0.79
The meningeal representation in the trigeminal ganglion--an experimental study in the cat. Headache (1984) 0.78
Cervical spinal cord neurons receiving sensory input from the cranial vasculature. Cephalalgia (1991) 0.77
Trigeminal primary afferent neurons projecting directly to the solitary nucleus in the cat: a transganglionic and retrograde horseradish peroxidase study. Neurosci Lett (1984) 0.76
Do intracranial and extracranial trigeminal afferents represent divergent axon collaterals? Neurosci Lett (1983) 0.76
Oral triptans (serotonin 5-HT(1B/1D) agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet (2001) 6.61
New appendix criteria open for a broader concept of chronic migraine. Cephalalgia (2006) 5.97
Guidelines for controlled trials of drugs in migraine: second edition. Cephalalgia (2000) 3.32
Hypothalamic activation in cluster headache attacks. Lancet (1998) 3.32
Oral sumatriptan in acute migraine. Lancet (1991) 2.87
The International Classification of Headache Disorders, 2nd Edition (ICHD-II)--revision of criteria for 8.2 Medication-overuse headache. Cephalalgia (2005) 2.86
Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials. Cephalalgia (2002) 2.78
A triptan too far? J Neurol Neurosurg Psychiatry (1998) 2.71
Correlation between structural and functional changes in brain in an idiopathic headache syndrome. Nat Med (1999) 2.67
EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol (2006) 2.43
EFNS guideline on the drug treatment of migraine--revised report of an EFNS task force. Eur J Neurol (2009) 2.39
Disability, HRQoL and resource use among chronic and episodic migraineurs: results from the International Burden of Migraine Study (IBMS). Cephalalgia (2010) 2.18
Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study. Cephalalgia (2007) 2.11
Premonitory symptoms in migraine: an electronic diary study. Neurology (2003) 1.81
Brainstem activation specific to migraine headache. Lancet (2001) 1.80
Ophthalmoplegic migraine: a recurrent demyelinating neuropathy? Cephalalgia (2001) 1.77
The trigeminovascular system in humans: pathophysiologic implications for primary headache syndromes of the neural influences on the cerebral circulation. J Cereb Blood Flow Metab (1999) 1.77
Migraine, aura, and cortical spreading depression: why are we still talking about it? Ann Neurol (2001) 1.74
Greater occipital nerve injection in primary headache syndromes--prolonged effects from a single injection. Pain (2006) 1.72
Proposals for new standardized general diagnostic criteria for the secondary headaches. Cephalalgia (2009) 1.68
Migraine: preventive treatment. Cephalalgia (2002) 1.63
Activation of the trigeminovascular system by mechanical distension of the superior sagittal sinus in the cat. Cephalalgia (1992) 1.62
A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain (2005) 1.59
Effect of cortical spreading depression on activity of trigeminovascular sensory neurons. Cephalalgia (1999) 1.58
Brainstem influences on the cephalic circulation: experimental data from cat and monkey of relevance to the mechanism of migraine. Headache (1983) 1.58
Intravenous aspirin (lysine acetylsalicylate) in the inpatient management of headache. Neurology (2010) 1.58
Oral zolmitriptan is effective in the acute treatment of cluster headache. Neurology (2000) 1.56
Ergotamine in the acute treatment of migraine: a review and European consensus. Brain (2000) 1.52
Mechanisms of oral-pharyngeal dysphagia in patients with Parkinson's disease. Gastroenterology (1996) 1.49
The neuropsychological profile of vascular cognitive impairment in stroke and TIA patients. Neurology (2004) 1.45
Double-blind clinical trials of oral triptans vs other classes of acute migraine medication - a review. Cephalalgia (2004) 1.45
The clinical characteristics of headache in patients with pituitary tumours. Brain (2005) 1.44
Cortical spreading depression-associated cerebral blood flow changes induced by mechanical stimulation are modulated by AMPA and GABA receptors. Cephalalgia (2010) 1.44
EFNS guideline on the drug treatment of migraine - report of an EFNS task force. Eur J Neurol (2006) 1.43
Serotonin infusions inhibit sensory input from the dural vasculature. Cephalalgia (1999) 1.40
Vasodilator agents and supracollicular transection fail to inhibit cortical spreading depression in the cat. Cephalalgia (1999) 1.38
Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse. Cephalalgia (2009) 1.29
Functional magnetic resonance imaging in spontaneous attacks of SUNCT: short-lasting neuralgiform headache with conjunctival injection and tearing. Ann Neurol (1999) 1.26
The periaqueductal grey matter modulates trigeminovascular input: a role in migraine? Neuroscience (2001) 1.24
Clinical determinants of dementia and mild cognitive impairment following ischaemic stroke: the Sydney Stroke Study. Dement Geriatr Cogn Disord (2006) 1.22
Diagnostic delays and mis-management in cluster headache. Acta Neurol Scand (2004) 1.22
Expression of c-Fos-like immunoreactivity in the caudal medulla and upper cervical spinal cord following stimulation of the superior sagittal sinus in the cat. Brain Res (1993) 1.21
Increased responses in trigeminocervical nociceptive neurons to cervical input after stimulation of the dura mater. Brain (2003) 1.21
Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS). J Headache Pain (2012) 1.19
Neural processing of craniovascular pain: a synthesis of the central structures involved in migraine. Headache (1991) 1.17
Animal models of migraine: looking at the component parts of a complex disorder. Eur J Neurosci (2006) 1.16
Decreased carotid arterial resistance in cats in response to trigeminal stimulation. J Neurosurg (1984) 1.15
Deep brain stimulation for intractable chronic cluster headache: proposals for patient selection. Cephalalgia (2004) 1.11
What happens to new-onset headache presented to primary care? A case-cohort study using electronic primary care records. Cephalalgia (2008) 1.10
Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption. Br J Pharmacol (1993) 1.10
Activation of 5-HT(1B/1D) receptor in the periaqueductal gray inhibits nociception. Ann Neurol (2004) 1.08
Stimulation of the superior sagittal sinus in the cat causes release of vasoactive peptides. Neuropeptides (1990) 1.06
PET and MRA findings in cluster headache and MRA in experimental pain. Neurology (2000) 1.06
Central activation of the trigeminovascular pathway in the cat is inhibited by dihydroergotamine. A c-Fos and electrophysiological study. Brain (1996) 1.05
Benign paroxysmal torticollis of infancy: four new cases and linkage to CACNA1A mutation. Dev Med Child Neurol (2002) 1.05
Nitric oxide synthase inhibitors can antagonize neurogenic and calcitonin gene-related peptide induced dilation of dural meningeal vessels. Br J Pharmacol (2002) 1.04
Vanilloid type 1 receptors (VR1) on trigeminal sensory nerve fibres play a minor role in neurogenic dural vasodilatation, and are involved in capsaicin-induced dural dilation. Br J Pharmacol (2003) 1.03
Neuropeptides in migraine and cluster headache. Cephalalgia (1994) 1.03
Magnetic resonance angiography in facial and other pain: neurovascular mechanisms of trigeminal sensation. J Cereb Blood Flow Metab (2001) 1.02
SUNCT syndrome responsive to intravenous lidocaine. Cephalalgia (2004) 1.02
Hypothalamic involvement and activation in cluster headache. Curr Pain Headache Rep (2001) 1.02
Calcitonin gene-related peptide and nitric oxide in the trigeminal ganglion: cerebral vasodilatation from trigeminal nerve stimulation involves mainly calcitonin gene-related peptide. J Auton Nerv Syst (1998) 1.02
Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology (2003) 1.02
Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias. Cephalalgia (2008) 1.01
Dopamine and migraine: biology and clinical implications. Cephalalgia (2007) 1.01
Trigeminovascular nociceptive transmission involves N-methyl-D-aspartate and non-N-methyl-D-aspartate glutamate receptors. Neuroscience (1999) 1.00
Differential modulation of nociceptive dural input to [hypocretin] orexin A and B receptor activation in the posterior hypothalamic area. Pain (2004) 1.00
The mode of action of sumatriptan is vascular? A debate. Cephalalgia (1994) 0.98
Substance P receptor antagonists in the therapy of migraine. Expert Opin Investig Drugs (2001) 0.98
Sumatriptan can inhibit trigeminal afferents by an exclusively neural mechanism. Brain (1996) 0.98
Gray matter changes related to chronic posttraumatic headache. Neurology (2009) 0.98
Fos expression in the midbrain periaqueductal grey after trigeminovascular stimulation. J Anat (2001) 0.98
SUNCT syndrome secondary to prolactinoma. J Neurol Neurosurg Psychiatry (2003) 0.98
Familial typical migraine: linkage to chromosome 19p13 and evidence for genetic heterogeneity. Neurology (1998) 0.97
Anandamide acts as a vasodilator of dural blood vessels in vivo by activating TRPV1 receptors. Br J Pharmacol (2004) 0.97
Secondary cluster headache responsive to sumatriptan. J Neurol Neurosurg Psychiatry (1995) 0.97
Microiontophoretic application of serotonin (5HT)1B/1D agonists inhibits trigeminal cell firing in the cat. Brain (1997) 0.97
Prolactinomas, dopamine agonists and headache: two case reports. Eur J Neurol (2003) 0.96
Benign cough headache. Cephalalgia (2002) 0.96
No change in the structure of the brain in migraine: a voxel-based morphometric study. Eur J Neurol (2003) 0.96
Glyceryl trinitrate triggers premonitory symptoms in migraineurs. Pain (2004) 0.95
Placebo response in cluster headache trials: a review. Cephalalgia (2003) 0.95
Amylin: localization, effects on cerebral arteries and on local cerebral blood flow in the cat. ScientificWorldJournal (2001) 0.94
SUNCT syndrome: prolonged attacks, refractoriness and response to topiramate. Neurology (2002) 0.94
Extracranial vasodilation mediated by vasoactive intestinal polypeptide (VIP). Brain Res (1985) 0.94
Evidence for an X-linked genetic component in familial typical migraine. Hum Mol Genet (1998) 0.94
Topiramate inhibits trigeminovascular neurons in the cat. Cephalalgia (2004) 0.93
Modulation of nociceptive dural input to the trigeminal nucleus caudalis via activation of the orexin 1 receptor in the rat. Eur J Neurosci (2006) 0.93
6-Mercaptopurine-related leucopenia and in vivo xanthine oxidase activity. Lancet (1986) 0.92
Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism. Br J Pharmacol (2003) 0.92
Why headache treatment fails. Neurology (2003) 0.92
Cluster headache. Cephalalgia (2000) 0.92
Distribution of 5-HT(1B), 5-HT(1D) and 5-HT(1F) receptor expression in rat trigeminal and dorsal root ganglia neurons: relevance to the selective anti-migraine effect of triptans. Brain Res (2010) 0.91
Significance of atypical presentation of symptomatic SUNCT: a case report. J Neurol Neurosurg Psychiatry (2001) 0.91
Orexin 1 receptor activation attenuates neurogenic dural vasodilation in an animal model of trigeminovascular nociception. J Pharmacol Exp Ther (2005) 0.90
The effects of the TRPV1 receptor antagonist SB-705498 on trigeminovascular sensitisation and neurotransmission. Naunyn Schmiedebergs Arch Pharmacol (2009) 0.90
Comparison of more and less lipophilic serotonin (5HT1B/1D) agonists in a model of trigeminovascular nociception in cat. Exp Neurol (1998) 0.90
Intravenous acetylsalicylic acid inhibits central trigeminal neurons in the dorsal horn of the upper cervical spinal cord in the cat. Headache (1994) 0.89